Vasodilation in the Management of Acute Congestive Heart Failure - VMAC

Description:

The VMAC trial was a randomized, double-blinded, placebo-controlled trial designed to test the safety and efficacy of intravenous (IV) nesiritide compared to placebo and IV nitroglycerin in the treatment of decompensated congestive heart failure (CHF).